Comparing two medications that reduces bp in women developing hypertension after delivery
Phase 3
- Conditions
- Health Condition 1: O165- Unspecified maternal hypertension,complicating the puerperium
- Registration Number
- CTRI/2024/03/063673
- Lead Sponsor
- Srm medical college hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Women with pre eclampsia, eclampsia or De nova postpartum hypertension
Exclusion Criteria
Women with absolute contraindications for amlodipine or labetalol , liver dosease disease, renal disease , asthma
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Comparison of time taken for each drug to control postpartum hypertension <br/ ><br>Compare the number of doses required to achieve bp control <br/ ><br>Timepoint: First 6 hours, 72 hours and 6 weeks postpartum <br/ ><br>
- Secondary Outcome Measures
Name Time Method Reduction in number of doses required by the patient during the hospital stayTimepoint: 72hrs